Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A rapidly growing primary carcinoma of the thyroid gland composed of malignant squamous cells. The clinical course is usually aggressive.
Biomarker and diagnostic research for thyroid gland squamous cell carcinoma has been reported in the published literature.
4 clinical trials registered. Interventions under study include drug therapy, other interventions, biologic therapy, and procedural interventions. Pipeline includes 4 PHASE2. Research is primarily sponsored by academic and government institutions.
177 publications have been identified in PubMed for thyroid gland squamous cell carcinoma. Research spans Basic Science / Preclinical (47%), Case Report / Case Series (15%), and Review / Meta-Analysis (12%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 83 |
Data assembled from 3 of 12 sources · Last updated Sep 18, 2026, 6:17 PM UTC
47%
Patient case studies | 26 | 15% |
Research summaries | 22 | 12% |
Testing and diagnosis research | 14 | 8% |
Clinical study results | 13 | 7% |
Disease patterns and progression | 13 | 7% |
New treatment approaches | 6 | 3% |
Bahsoun A (2026). [PMID: 42156098](https://pubmed.ncbi.nlm.nih.gov/42156098/). *BMJ Case Rep*. [Case Report / Case Series]
Zhang Q (2026). [PMID: 42171146](https://pubmed.ncbi.nlm.nih.gov/42171146/). *Endocr Relat Cancer*. [Basic Science / Preclinical]
Loberg MA (2026). [PMID: 41480746](https://pubmed.ncbi.nlm.nih.gov/41480746/). *JCI insight*. [Epidemiology / Natural History]
Hong MH (2026). [PMID: 41449287](https://pubmed.ncbi.nlm.nih.gov/41449287/). *Esophagus : official journal of the Japan Esophageal Society*. [Case Report / Case Series]
Dixit S (2026). [PMID: 41545802](https://pubmed.ncbi.nlm.nih.gov/41545802/). *Virchows Archiv : an international journal of pathology*. [Case Report / Case Series]
Zou M (2026). [PMID: 41808291](https://pubmed.ncbi.nlm.nih.gov/41808291/). *Autoimmunity*. [Basic Science / Preclinical]
Finnegan EA (2026). [PMID: 41603381](https://pubmed.ncbi.nlm.nih.gov/41603381/). *J Clin Endocrinol Metab*. [Review / Meta-Analysis]
Shan G (2026). [PMID: 40618449](https://pubmed.ncbi.nlm.nih.gov/40618449/). *Biomaterials*. [Basic Science / Preclinical]
Tellawi I (2026). [PMID: 42179376](https://pubmed.ncbi.nlm.nih.gov/42179376/). *Case Rep Oncol*. [Case Report / Case Series]
Ashorobi D (2026). [PMID: 30969597](https://pubmed.ncbi.nlm.nih.gov/30969597/). *Unknown Journal*. [Basic Science / Preclinical]